In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
Plant-based artificial Christmas trees set to launch this December
In California, artificial Christmas tree maker Balsam Brands will launch a new line of trees for 2025’s holiday season that use needles made of...
Artist Sam Shoemaker takes mushroom kayak on twelve-hour journey
In California, an artist and “mycologist” has crossed 26 miles of ocean in a kayak made of mycelium, the root system of mushrooms.
Sam...
Canadian funeral group becomes first to offer Loop’s mycelium coffins and urns
In Canada, Mount Pleasant Group’s Meadowvale Cemetery, Funeral and Cremation Centres have become the first in Canada to offer the Loop Living Cocoon and...